| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2222.2011.03695.X |
| P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2222.2011.03695.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2222.2011.03695.x | ||
| P698 | PubMed publication ID | 21395878 |
| P50 | author | Regine Audran | Q92594903 |
| P2093 | author name string | A. Mercenier | |
| N. Barbier | |||
| F. Spertini | |||
| J. Moulin | |||
| V. Aubert | |||
| S. Nutten | |||
| J. Wassenberg | |||
| P2860 | cites work | Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study | Q79770772 |
| The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance | Q80826759 | ||
| A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis | Q28307749 | ||
| The effect of infections on susceptibility to autoimmune and allergic diseases | Q29618525 | ||
| Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. | Q33999211 | ||
| Quality of life in patients with allergic rhinitis | Q34095826 | ||
| Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen | Q34194609 | ||
| The immunological basis of the hygiene hypothesis | Q34476487 | ||
| Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
| World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) | Q34589248 | ||
| Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. | Q36261169 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Regulation of IgE homeostasis, and the identification of potential targets for therapeutic intervention | Q36673190 | ||
| The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy | Q39836406 | ||
| Treatment of perennial allergic rhinitis with lactic acid bacteria | Q40536879 | ||
| Effects of probiotics on atopic dermatitis | Q42706244 | ||
| Levocetirizine better protects than desloratadine in a nasal provocation with allergen | Q44853677 | ||
| Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis | Q46080379 | ||
| Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge | Q46879661 | ||
| Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice | Q48318531 | ||
| The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite | Q53285097 | ||
| Probiotics for the treatment or prevention of eczema | Q57341748 | ||
| Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma | Q59054619 | ||
| Evaluation of acoustic rhinometry in a nasal provocation test with allergen | Q73039204 | ||
| Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing | Q73375788 | ||
| Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge | Q73922690 | ||
| The intestinal microflora in allergic Estonian and Swedish 2-year-old children | Q77321890 | ||
| Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen | Q77846726 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lacticaseibacillus casei | Q139777 |
| Lacticaseibacillus paracasei | Q1799829 | ||
| pollen | Q79932 | ||
| nasal provocation test | Q16919342 | ||
| P304 | page(s) | 565-573 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis | |
| P478 | volume | 41 |
| Q45161101 | Characterization of Candidate Anti-Allergic Probiotic Strains in a Model of Th2-Skewed Human Peripheral Blood Mononuclear Cells |
| Q36834812 | Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper |
| Q37285699 | Clinical efficacy and mechanism of probiotics in allergic diseases |
| Q30443010 | Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis |
| Q38062586 | Developments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy |
| Q37072738 | Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability |
| Q44167428 | Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study). |
| Q104616202 | First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients |
| Q82628304 | Follow‐up of probiotic Lactobacillus GG effects on allergic sensitization and asthma in infants at risk |
| Q34432074 | House dust mite allergy: environment evaluation and disease prevention |
| Q55481967 | House dust mite-related respiratory allergies and probiotics: a narrative review. |
| Q38169956 | Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and impact on skin defences |
| Q85856203 | Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial |
| Q36587241 | Immunomodulatory Activity ofLactococcus lactisA17 from Taiwan Fermented Cabbage in OVA-Sensitized BALB/c Mice |
| Q36057420 | Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice |
| Q39370979 | Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. |
| Q41773158 | Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season |
| Q33769067 | Oral administration of heat-inactivated Lactobacillus plantarum K37 modulated airway hyperresponsiveness in ovalbumin-sensitized BALB/c mice |
| Q38097976 | Probiotic effects in allergic disease |
| Q38215758 | Probiotics in the treatment of chronic rhinoconjunctivitis and chronic rhinosinusitis. |
| Q37952138 | The impact of bacterial infection on mast cell degranulation |
| Q34309689 | The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures |
| Q48543528 | Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years |
| Q38148192 | Treatment of allergic rhinitis with probiotics: an alternative approach |
| Q41822453 | rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. |
Search more.